Palatin Technologies
PTN
#9998
Rank
โ‚น2.93 B
Marketcap
โ‚น1,722
Share price
-9.61%
Change (1 day)
2,596.61%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚น0.4 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚น8.84 Million. In 2024 the company made an earning of -โ‚น2.44 Billion, an increase over its 2023 earnings that were of -โ‚น2.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.4 Billion-83.73%
2024 -โ‚น2.44 Billion-16.9%
2023 -โ‚น2.93 Billion5.99%
2022 -โ‚น2.76 Billion-13.7%
2021 -โ‚น3.2 Billion33.25%
2020 -โ‚น2.4 Billion-172.11%
2019 โ‚น3.32 B2352.33%
2018 โ‚น0.13 B-94.13%
2017 โ‚น2.31 B-154.92%
2016 -โ‚น4.22 Billion3.67%
2015 -โ‚น4.07 Billion878%
2014 -โ‚น0.42 Billion-72.64%
2013 -โ‚น1.52 Billion-33.11%
2012 -โ‚น2.27 Billion77.71%
2011 -โ‚น1.28 Billion
2003 -โ‚น2.17 Billion29.93%
2002 -โ‚น1.67 Billion36.18%
2001 -โ‚น1.23 Billion
1999 -โ‚น1.02 Billion6.04%
1998 -โ‚น0.96 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚น1.09 Billion 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.67 Billion 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น52.62 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น4.56 B-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น6.02 B-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.62 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.922 T-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.02 Billion 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.181 T-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK